Skip to main content
SpringerLink
Log in
Book cover

Reproduktionsmedizin pp 1–9Cite as

Uterus myomatosus

  • Living reference work entry
  • First Online:

  • 221 Accesses

Part of the book series: Springer Reference Medizin ((SRM))

Zusammenfassung

Das Leiomyom ist der häufigste Tumor des weiblichen Geschlechtsorgans. Bei 25–50 % der Myomträgerinnen treten Symptome wie pathologische Blutungen, eine blutungsbedingte Anämie, habituelle Aborte oder eine Sterilität auf. Medikamentöse Therapien basieren auf einer ovariellen Funktionssuppression durch GnRH-Analoga oder dem Einsatz selektiver Progesteron-Rezeptor-Modulatoren. Im Falle pathologischer Blutungen in der Perimenopause ist die Hysterektomie die adäquate Therapie. Neben der vaginalen Hysterektomie stehen die totale laparoskopische Hysterektomie, die laparoskopisch assistierte suprazervikale Hysterektomie oder die Hysterektomie per laparotomiam zu Verfügung. Konservative Verfahren sind die Myomenukleation per laparoskopiam oder laparotomiam, die hysteroskopische Myomabtragung, die Embolisation der A. uterina oder deren Koagulation, die Applikation von hochenergetischem Ultraschall oder die transzervikale ultraschallgesteuerte Hochfrequenzablation.

This is a preview of subscription content, log in via an institution.

Literatur

  • Abbott JA, Garry R (2002) The surgical management of menorrhagia. Hum Reprod Update 8:68–78

    Article  PubMed  Google Scholar 

  • Arena S, Zupi E (2011) Heavy menstrual bleeding: considering the most effective treatment option. Women’s Health 7:143–146

    PubMed  Google Scholar 

  • Arici A, Sozen I (2000) Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril 73:1006–1011

    Article  CAS  PubMed  Google Scholar 

  • Bends R, Brössner A et al (2016) Myoma in statu nascendi nach transcervikaler Hochfrequenzablation eines transmuralen Leiomyoms des Uterus. Gynecol Endocrinol 14:291–294

    Google Scholar 

  • Bernard G, Darai E, Poncelet C et al (2000) Fertility after hysteroscopic myomectomy: effect of intramural myomas associated. Eur J Obstet Gynecol Reprod Biol 88:85–90

    Article  CAS  PubMed  Google Scholar 

  • Bongers M, Brölmann H et al (2015) Transcervical, intrauterine ultrasound guided radiofrequency ablation of uterine fibroids with the VizAblate-System: three- and six-month endpoint results from the FAST-EU study. Gynecol Surg 12:61–70

    Article  PubMed  Google Scholar 

  • Boruta DM, Shibley T (2016) Power morcellation of unsuspected high – grade leiomyosarcoma within inflated containment bag: 2 – year follow up. J Minim Invasive Gynecol 23:1009–1011

    Article  PubMed  Google Scholar 

  • Brill AI (2009) Treatment of fibroids via uterine artery occlusion (uterine artery embolization and Doppler-guided uterine artery occlusion) potential role in today’s armamentarium. Arch Gynecol Obstet 280:513–520

    Article  PubMed  Google Scholar 

  • Brosens I, Johannisson E, Dal Cin P, Deprest J, Van den Berghe H (1996) Analysis of the karyotype and desoxyribonucleic acid content of uterine myomas in premenopausal, menopausal and gonadotropin-releasing hormone agonist treated females. Fertil Steril 66:376–379

    Article  CAS  PubMed  Google Scholar 

  • Buchi K, Keller PJ (1980) Estrogen receptors in normal and myomatous human uteri. Gynecol Obstet Investig 11:59–60

    Google Scholar 

  • Burbank F, Hutchins FL Jr (2000) Uterine artery occlusion by embolization or surgery for the treatment of fibroids: a unifying hypothesis-transient uterine ischemia. J Am Gynecol Laparosc 7:S1–S49

    Article  Google Scholar 

  • Buttram VC, Reiter RC (1981) Uterine leiomyomata: etiology, symptomatology and management. Fertil Steril 36:433–445

    Article  PubMed  Google Scholar 

  • Cirkel U, Ochs H, Schneider HPG (1992) Experience with leuprorelin acetate depot in the treatment of fibroids: a German multicentre study. Clin Ther 14:37–44

    PubMed  Google Scholar 

  • Coddington CC, Collins RL, Shawker TH, Anderson R, Lynn Loriaux D, Winkel CA (1986) Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri. Fertil Steril 45:624–629

    Article  CAS  PubMed  Google Scholar 

  • Creighton S, Bourne TH, Lawton FG et al (1994) Use of transvaginal ultrasonography with color Doppler imaging to determine an appropriate treatment regimen for uterine fibroids with a GnRH agonist before surgery: a preliminary study. Ultrasound Obstet Gynecol 4:494–498

    Article  CAS  PubMed  Google Scholar 

  • Day Baird D, Dunson DB et al (2003) High cumulative incidence of uterine leiomyomata in black and white women: ultrasound evidence. Am J Obstet Gynecol 188:100–107

    Article  Google Scholar 

  • Donnez J, Mathieu PE, Bassil S, Smets M, Nisolle M, Berliere M (1996) Laparoscopic myomectomy today. Hum Reprod 11:1837–1840

    Article  CAS  PubMed  Google Scholar 

  • Donnez J, Dolmans MM et al (2016) Uterine fibroid management: from the present to the future. Hum Reprod Update 22:665–685

    Article  PubMed  PubMed Central  Google Scholar 

  • Doridot V, Dubuisson JB, Chapron C, Fauconnier A et al (2001) Recurrence of leiomyomata after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc 8:495–500

    Article  CAS  PubMed  Google Scholar 

  • Dubuisson JB, Lecuru F, Foulot H et al (1992) Myomectomy by laparoscopy: a preliminary report of 43 cases. Fertil Steril 56:827

    Article  Google Scholar 

  • Dubuisson JB, Chapron C, Mouly M et al (1994) Laparoscopic myomectomy. In: Donnez J, Nisolle M (Hrsg) An atlas of laser laparoscopy and hysteroscopy. Parthenon, New York, S 187–193

    Google Scholar 

  • Farhi J, Askhenazi J, Feldberg D, Dicker D, Orvieto R et al (1995) Effect of uterine leiomyomata on the results of in-vitro-fertilization treatment. Hum Reprod 10:2576–2578

    Article  CAS  PubMed  Google Scholar 

  • Felberbaum RE, Germer U, Ludwig M, Riethmüller-Winzen H, Heise S, Buttge I, Bauer O, Reissmann T, Engel J, Diedrich K (1998) Treatment of uterine fibroids with a slow release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix. Hum Reprod 13:1660–1668

    Article  CAS  PubMed  Google Scholar 

  • Filicori M, Hall DA, Loughlin JS, Rivier J, Vale W, Crowle WF (1983) A conservative approach to the management of uterine leiomyomata: pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am J Obstet Gynecol 147:72

    Article  Google Scholar 

  • Findlay S (1990) The health-insurance factor. US News World Rep 30:157

    Google Scholar 

  • Friedman AJ, Barbieri RL, Benacerraf BR, Schiff I (1987) Treatment of leiomyomata with intranasla or subcutanous leuprolide, a gonadotropin-releasing hormone agonist. Fertil Steril 48:560–564

    Article  CAS  PubMed  Google Scholar 

  • Frishman GN, Jurema MW (2005) Myomas and myomectomy. J Minim Invasive Gynecol 12:443–456

    Article  PubMed  Google Scholar 

  • Funaki K, Fukunishi H, Sawada K (2009) Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas. 24 month follow-up. Ultrasound Obstet Gynecol 34:584–589

    Google Scholar 

  • Ginsburg ES, Benosn CB, Garfield JM et al (1993) The effect of operative technique and uterine size on blood loss during myomectomy: a prospective randomized study. Fertil Steril 60:956–962

    Article  CAS  PubMed  Google Scholar 

  • Goldfarb HA (1999) Combining myoma coagulation with endometrial ablation/resection reduces subsequent surgery rates. JSLS 3:253–260

    PubMed  PubMed Central  CAS  Google Scholar 

  • Hartmann KE, Birnbaum H, Ben-Hamadi R, Wu EQ, Farrell MH, Spalding J, Stang P (2006) Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol 108:930–937

    Article  PubMed  Google Scholar 

  • Hindley J, Gedroyc WM, Regan L, Stewart E, Tempany C, Hynyen K, Mc Donnold N, Inbar Y, Itzchak Y, Rabinovici J, Kim HS, Geschwind JF, Hesley G, Gostout B, Ehrenstein T, Hengst S, Sklair-Levy M, Shushan A, Jolesz F (2004) MRI guidance of focussed ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol 183:1713–1719

    Article  PubMed  Google Scholar 

  • Jacobson GF, Shaber RE, Armstrong MA, Hung YY (2007) Changes in rates of hysterectomy and uterine conserving procedures for treatment of uterine lyomyoma. Am J Obstet Gynecol 196:601.e1–601.e6

    Article  Google Scholar 

  • Kawaguchi K, Fujii S, Konishi I, Iwai T, Nanbu Y, Nonogaki H (1991) Immunohistochemical analysis of estrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy. Virchows Arch [Pathol Anat] 419:309–315

    Article  CAS  Google Scholar 

  • Kundu S, Zachen M et al (2017) Sarcoma risk in uterine surgery in a tertiary university hospital in germany. Int J Gynecol Cancer 27:961–966

    Article  PubMed  Google Scholar 

  • Lichtinger M, Herbert S, Memmolo A (2005) Temporary, transvaginal occlusion of the uterine arteries: a feasibility and safety study. J Minim Invasive Gynecol 12:40–42

    Article  PubMed  Google Scholar 

  • Luo X, Ding L, Xu J, Chegini N (2005) Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology 146:1097–1118

    Article  CAS  PubMed  Google Scholar 

  • Maresh MJA, Netcalfe MA, McPherson K et al (2002) The VALUE national hysterectomy study: description of the patients and their surgery. BJOG 109:302–312

    Article  CAS  PubMed  Google Scholar 

  • Martin-Chavez EB, Brum IS, Stoll J, Capp E, Corleta HE (2004) Insulin-like-growth-factor I receptor mRNA expression and autophosphorylation in human myometrium and leiomyoma. Gynecol Obstet Investig 57:210–213

    Article  CAS  Google Scholar 

  • Narayam R, Goswamy RK (1994) Treatment of submucous fibroids and outcome of assisted conception. J Am Assoc Gynecol Laparosc I:307–311

    Article  Google Scholar 

  • Nezhat C, Nezhat F, Silfen SL et al (1991) Laparoscopic myomectomy. Int J Fertil 36:275–280

    PubMed  CAS  Google Scholar 

  • Nisolle M, Smets M, Malvaux V, Anaf V, Donnez J (1993) Laparoscopic myolysis with Nd: YAG laser. J Gynecol Surg 9:95–99

    Article  CAS  PubMed  Google Scholar 

  • Oliver JA Jr, Lance JS (1979) Selective embolization to control massive hemorrhage following pelvic surgery. Am J Obstet Gynecol 135:431–432

    Article  PubMed  Google Scholar 

  • Pados G, Tsolakidis D et al (2017) Prevalence of occult leiomyosarcomas and atypical leiomyomas after laparoscopic morcellation of leiomyomas in reproductive – age women. Hum Reprod 32:2036–2041

    Article  CAS  PubMed  Google Scholar 

  • Pandis N, Heim S, Willen H, Bardi G, Flodérus UM, Mandahl N (1991) Histologic-cytogenetic correlations in uterine leiomyomas. Int J Gynecol Cancer 1:163–168

    Article  Google Scholar 

  • Park KH, Kim JY, Shin JS et al (2003) Treatment outcomes of uterine embolization and laparoscopic uterine artery ligation for uterine myoma. Yonsei Med J 44:694–702

    Article  PubMed  Google Scholar 

  • Parker WH (2007) Etiology, symptomatology and diagnosis of uterine myomas. Fertil Steril 87:725–736

    Article  PubMed  Google Scholar 

  • Phillips DR, Nathanson HG, Milim SJ, Haselkorn JS (1996) Laparoscopic leiomyoma coagulation. J Am Assoc Gynecol Laparosc 3:S39

    PubMed  Google Scholar 

  • Pollow K, Geilfuss J, Boquoi E, Pollow B (1978) Estrogen and progesterone binding proteins in normal human myometrium and leiomyoma tissue. J Clin Chem Clin Biochem 16:503–511

    PubMed  CAS  Google Scholar 

  • Seracchioli R, Rossi S, Govoni F, Rossi E, Venturoli S, Bulletti C, Flamigni C (2000) Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod 15:2663–2668

    Article  CAS  PubMed  Google Scholar 

  • Sharp HT (2006) Assessment of new technology in the treatment of idiopathic menorrhagia and uterine leiomyomata. Obstet Gynecol 108:990–1003

    Article  PubMed  Google Scholar 

  • Spies JB, Cooper JM et al (2004) Outcome of uterine embolization and hysterectomy for leiomyomas: results of a multicenter study. Am J Obstet Gynecol 191:22–31

    Article  PubMed  Google Scholar 

  • Stewart EA, Rabinovici J, Tempany CM et al (2006) Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 85:22–29

    Article  PubMed  Google Scholar 

  • Sunkara SK, Khairy M, El-Toukhy T, Khalaf Y, Coomarasamy A (2010) The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis. Hum Reprod 25:418–429

    Article  PubMed  Google Scholar 

  • Townsend DE, Sparkes RS, Baluda MC, McClelland G (1970) Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis of glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol 107:1168–1173

    Article  CAS  PubMed  Google Scholar 

  • Varasteh NN, Neuwirth RS et al (1999) Pregnancy rates after hysteroscopic polypectomy and myomectomy in infertile women. Obstet Gynecol 94:168–171

    PubMed  CAS  Google Scholar 

  • Vilos GA, Hollett-Caines J, Burbank F (2006) Uterine artery occlusion: what is the evidence? Clin Obstet Gynecol 49:798–810

    Article  PubMed  Google Scholar 

  • Volkers NA, Hehenkamp WJ, Birnie E et al (2007) Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years’ outcome from the randomized EMMY trial. Am J Obstet Gynecol 165:519.e1–519.e11

    Article  Google Scholar 

  • Wamsteker K, Emanuel MH, de Kruif JH (1993) Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension. Obstet Gynecol 82:736–740

    PubMed  CAS  Google Scholar 

  • Wilson EA, Yang F, Rees ED (1980) Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissue. Obstet Gynecol 55:20–24

    PubMed  CAS  Google Scholar 

  • Zander J (1986) Milestones in gynecology and obstetrics. In: Ludwig H, Thomsen K (Hrsg) Proceedings of the XIth world congress of gynecology and obstetrics, Berlin, 1985. Springer, Berlin/Heidelberg/New York, S 3–24

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Frauenheilkunde und Geburtshilfe, Klinikum Kempten Klinikverbund Kempten – Oberallgäu, Kempten, Deutschland

    Ricardo E. Felberbaum

Authors
  1. Ricardo E. Felberbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ricardo E. Felberbaum .

Editor information

Editors and Affiliations

  1. Facharzt-Zentrum für Kinderwunsch, Pränatale Medizin, Endokrinologie und Osteologie Hamburg GmbH, amedes experts, Hamburg, Germany

    Klaus Diedrich

  2. SYNLAB Holding Deutschland GmbH, Augsburg, Hamburg, Germany

    Michael Ludwig

  3. Sektion für gynäkologische Endokrinologie und Reproduktionsmedizin, UNIVERSITÄTSKLINIKUM Schleswig-Holstein – Campus Lübeck, Lübeck, Schleswig-Holstein, Germany

    Georg Griesinger

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Felberbaum, R.E. (2018). Uterus myomatosus. In: Diedrich, K., Ludwig, M., Griesinger, G. (eds) Reproduktionsmedizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55601-6_38-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-55601-6_38-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-55601-6

  • Online ISBN: 978-3-662-55601-6

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Search

Navigation